ParkinsonCanadaV1, Ncbi, Merge, bibRecord, 001363

Factors associated with the development of impulse compulsive disorders in Parkinson patients.

Identifieur interne : 001363 ( Ncbi/Merge ); précédent : 001362; suivant : 001364

Factors associated with the development of impulse compulsive disorders in Parkinson patients.

Auteurs : Abdul Qayyum Rana [Canada] ; Wasim Mansoor ; Syed Hussaini ; Abdullah Al Mosabbir ; Maniza Rahman ; Labiba Rahman

Source :

The International journal of neuroscience [ 1563-5279 ] ; 2013.

RBID : pubmed:23336737

Descripteurs français

Wicri :
- geographic : Canada.

English descriptors

KwdEn :
- Adult, Age of Onset, Aged, Canada (epidemiology), Disruptive, Impulse Control, and Conduct Disorders (chemically induced), Disruptive, Impulse Control, and Conduct Disorders (complications), Disruptive, Impulse Control, and Conduct Disorders (epidemiology), Dopamine Agonists (administration & dosage), Dopamine Agonists (adverse effects), Female, Humans, Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Parkinson Disease (psychology), Prevalence, Risk Factors, Sex Characteristics.
MESH :
- chemical , administration & dosage : Dopamine Agonists.
- chemical , adverse effects : Dopamine Agonists.
- geographic , epidemiology : Canada.
- chemically induced : Disruptive, Impulse Control, and Conduct Disorders.
- complications : Disruptive, Impulse Control, and Conduct Disorders, Parkinson Disease.
- drug therapy : Parkinson Disease.
- epidemiology : Disruptive, Impulse Control, and Conduct Disorders, Parkinson Disease.
- psychology : Parkinson Disease.
- Adult, Age of Onset, Aged, Female, Humans, Male, Middle Aged, Prevalence, Risk Factors, Sex Characteristics.

Abstract

The aim of this study is to identify the prevalence of impulse compulsive disorder (ICD) in Parkinson's disease (PD) patients and to study potential associative factors that may be related to the onset of ICD while on parkinsonian medications.

DOI: 10.3109/00207454.2013.768243
PubMed: 23336737

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000897
to stream PubMed, to step Curation: 000897
to stream PubMed, to step Checkpoint: 000897

Links to Exploration step

pubmed:23336737

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Factors associated with the development of impulse compulsive disorders in Parkinson patients.</title>
<author><name sortKey="Rana, Abdul Qayyum" sort="Rana, Abdul Qayyum" uniqKey="Rana A" first="Abdul Qayyum" last="Rana">Abdul Qayyum Rana</name>
<affiliation wicri:level="1"><nlm:affiliation>Parkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada. ranaaq@yahoo.com</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Parkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mansoor, Wasim" sort="Mansoor, Wasim" uniqKey="Mansoor W" first="Wasim" last="Mansoor">Wasim Mansoor</name>
</author>
<author><name sortKey="Hussaini, Syed" sort="Hussaini, Syed" uniqKey="Hussaini S" first="Syed" last="Hussaini">Syed Hussaini</name>
</author>
<author><name sortKey="Al Mosabbir, Abdullah" sort="Al Mosabbir, Abdullah" uniqKey="Al Mosabbir A" first="Abdullah" last="Al Mosabbir">Abdullah Al Mosabbir</name>
</author>
<author><name sortKey="Rahman, Maniza" sort="Rahman, Maniza" uniqKey="Rahman M" first="Maniza" last="Rahman">Maniza Rahman</name>
</author>
<author><name sortKey="Rahman, Labiba" sort="Rahman, Labiba" uniqKey="Rahman L" first="Labiba" last="Rahman">Labiba Rahman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23336737</idno>
<idno type="pmid">23336737</idno>
<idno type="doi">10.3109/00207454.2013.768243</idno>
<idno type="wicri:Area/PubMed/Corpus">000897</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000897</idno>
<idno type="wicri:Area/PubMed/Curation">000897</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000897</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000897</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000897</idno>
<idno type="wicri:Area/Ncbi/Merge">001363</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Factors associated with the development of impulse compulsive disorders in Parkinson patients.</title>
<author><name sortKey="Rana, Abdul Qayyum" sort="Rana, Abdul Qayyum" uniqKey="Rana A" first="Abdul Qayyum" last="Rana">Abdul Qayyum Rana</name>
<affiliation wicri:level="1"><nlm:affiliation>Parkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada. ranaaq@yahoo.com</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Parkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mansoor, Wasim" sort="Mansoor, Wasim" uniqKey="Mansoor W" first="Wasim" last="Mansoor">Wasim Mansoor</name>
</author>
<author><name sortKey="Hussaini, Syed" sort="Hussaini, Syed" uniqKey="Hussaini S" first="Syed" last="Hussaini">Syed Hussaini</name>
</author>
<author><name sortKey="Al Mosabbir, Abdullah" sort="Al Mosabbir, Abdullah" uniqKey="Al Mosabbir A" first="Abdullah" last="Al Mosabbir">Abdullah Al Mosabbir</name>
</author>
<author><name sortKey="Rahman, Maniza" sort="Rahman, Maniza" uniqKey="Rahman M" first="Maniza" last="Rahman">Maniza Rahman</name>
</author>
<author><name sortKey="Rahman, Labiba" sort="Rahman, Labiba" uniqKey="Rahman L" first="Labiba" last="Rahman">Labiba Rahman</name>
</author>
</analytic>
<series><title level="j">The International journal of neuroscience</title>
<idno type="eISSN">1563-5279</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Age of Onset</term>
<term>Aged</term>
<term>Canada (epidemiology)</term>
<term>Disruptive, Impulse Control, and Conduct Disorders (chemically induced)</term>
<term>Disruptive, Impulse Control, and Conduct Disorders (complications)</term>
<term>Disruptive, Impulse Control, and Conduct Disorders (epidemiology)</term>
<term>Dopamine Agonists (administration & dosage)</term>
<term>Dopamine Agonists (adverse effects)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (psychology)</term>
<term>Prevalence</term>
<term>Risk Factors</term>
<term>Sex Characteristics</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Disruptive, Impulse Control, and Conduct Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Disruptive, Impulse Control, and Conduct Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Disruptive, Impulse Control, and Conduct Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Age of Onset</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Risk Factors</term>
<term>Sex Characteristics</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The aim of this study is to identify the prevalence of impulse compulsive disorder (ICD) in Parkinson's disease (PD) patients and to study potential associative factors that may be related to the onset of ICD while on parkinsonian medications.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23336737</PMID>
<DateCreated><Year>2013</Year>
<Month>06</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>06</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1563-5279</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>123</Volume>
<Issue>7</Issue>
<PubDate><Year>2013</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>The International journal of neuroscience</Title>
<ISOAbbreviation>Int. J. Neurosci.</ISOAbbreviation>
</Journal>
<ArticleTitle>Factors associated with the development of impulse compulsive disorders in Parkinson patients.</ArticleTitle>
<Pagination><MedlinePgn>503-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3109/00207454.2013.768243</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study is to identify the prevalence of impulse compulsive disorder (ICD) in Parkinson's disease (PD) patients and to study potential associative factors that may be related to the onset of ICD while on parkinsonian medications.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">The study was conducted in two parts. In Part A, the prevalence of ICD in 140 PD patients was first assessed, followed by identifying any common variables that may be associated with the development of ICD. Finally, using a detailed chart review, Part B of the study examined the prevalence of ICD in all patients who presented with identical risk factors gathered in Part A.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 140 patients, 8 patients developed symptoms of ICD. Seven of these patients were found to have five common variables that included gender (males), stages 1-2 of PD, young onset of PD, maximum dosage of the drug and the use of dopamine agonists (DAs). Of the 140 patients, 22 patients fit the above-mentioned five criteria and of those 22 patients, 33% developed symptoms of ICD.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The use of DA therapy in the treatment of PD patients should be carefully monitored, especially in younger male patients who exhibit early signs of parkinsonian symptoms. As such, it is crucial for physicians to adjust DA dosages while also seeking alternative treatments to avoid the risk of ICD while on DAs.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rana</LastName>
<ForeName>Abdul Qayyum</ForeName>
<Initials>AQ</Initials>
<AffiliationInfo><Affiliation>Parkinson's Clinic of Eastern Toronto and Movement Disorders Center, Toronto, ON, Canada. ranaaq@yahoo.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mansoor</LastName>
<ForeName>Wasim</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hussaini</LastName>
<ForeName>Syed</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Al Mosabbir</LastName>
<ForeName>Abdullah</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rahman</LastName>
<ForeName>Maniza</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rahman</LastName>
<ForeName>Labiba</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>02</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Int J Neurosci</MedlineTA>
<NlmUniqueID>0270707</NlmUniqueID>
<ISSNLinking>0020-7454</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007174" MajorTopicYN="N">Disruptive, Impulse Control, and Conduct Disorders</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012727" MajorTopicYN="Y">Sex Characteristics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>6</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">23336737</ArticleId>
<ArticleId IdType="doi">10.3109/00207454.2013.768243</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><noCountry><name sortKey="Al Mosabbir, Abdullah" sort="Al Mosabbir, Abdullah" uniqKey="Al Mosabbir A" first="Abdullah" last="Al Mosabbir">Abdullah Al Mosabbir</name>
<name sortKey="Hussaini, Syed" sort="Hussaini, Syed" uniqKey="Hussaini S" first="Syed" last="Hussaini">Syed Hussaini</name>
<name sortKey="Mansoor, Wasim" sort="Mansoor, Wasim" uniqKey="Mansoor W" first="Wasim" last="Mansoor">Wasim Mansoor</name>
<name sortKey="Rahman, Labiba" sort="Rahman, Labiba" uniqKey="Rahman L" first="Labiba" last="Rahman">Labiba Rahman</name>
<name sortKey="Rahman, Maniza" sort="Rahman, Maniza" uniqKey="Rahman M" first="Maniza" last="Rahman">Maniza Rahman</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Rana, Abdul Qayyum" sort="Rana, Abdul Qayyum" uniqKey="Rana A" first="Abdul Qayyum" last="Rana">Abdul Qayyum Rana</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001363 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001363 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:23336737
   |texte=   Factors associated with the development of impulse compulsive disorders in Parkinson patients.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:23336737" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Factors associated with the development of impulse compulsive disorders in Parkinson patients.

Factors associated with the development of impulse compulsive disorders in Parkinson patients.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki